Literature DB >> 28168807

Hypoxia-induced HIF1α targets in melanocytes reveal a molecular profile associated with poor melanoma prognosis.

Stacie K Loftus1, Laura L Baxter1, Julia C Cronin1, Temesgen D Fufa1, William J Pavan1.   

Abstract

Hypoxia and HIF1α signaling direct tissue-specific gene responses regulating tumor progression, invasion, and metastasis. By integrating HIF1α knockdown and hypoxia-induced gene expression changes, this study identifies a melanocyte-specific, HIF1α-dependent/hypoxia-responsive gene expression signature. Integration of these gene expression changes with HIF1α ChIP-Seq analysis identifies 81 HIF1α direct target genes in melanocytes. The expression levels for 10 of the HIF1α direct targets - GAPDH, PKM, PPAT, DARS, DTWD1, SEH1L, ZNF292, RLF, AGTRAP, and GPC6 - are significantly correlated with reduced time of disease-free status in melanoma by logistic regression (P-value = 0.0013) and ROC curve analysis (AUC = 0.826, P-value < 0.0001). This HIF1α-regulated profile defines a melanocyte-specific response under hypoxia, and demonstrates the role of HIF1α as an invasive cell state gatekeeper in regulating cellular metabolism, chromatin and transcriptional regulation, vascularization, and invasion. Published 2017. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  HIF1α; hypoxia; melanocyte; melanoma; metastasis

Mesh:

Substances:

Year:  2017        PMID: 28168807      PMCID: PMC5411287          DOI: 10.1111/pcmr.12579

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  46 in total

1.  Oxygen levels in normal and previously irradiated human skin as assessed by EF5 binding.

Authors:  Sydney M Evans; Amy E Schrlau; Ara A Chalian; Paul Zhang; Cameron J Koch
Journal:  J Invest Dermatol       Date:  2006-06-29       Impact factor: 8.551

2.  p16(Ink4a) in melanocyte senescence and differentiation.

Authors:  Elena V Sviderskaya; Simon P Hill; Tracy J Evans-Whipp; Lynda Chin; Seth J Orlow; David J Easty; Sok Ching Cheong; David Beach; Ronald A DePinho; Dorothy C Bennett
Journal:  J Natl Cancer Inst       Date:  2002-03-20       Impact factor: 13.506

3.  ATRAP, novel AT1 receptor associated protein, enhances internalization of AT1 receptor and inhibits vascular smooth muscle cell growth.

Authors:  T Cui; H Nakagami; M Iwai; Y Takeda; T Shiuchi; K Tamura; L Daviet; M Horiuchi
Journal:  Biochem Biophys Res Commun       Date:  2000-12-29       Impact factor: 3.575

4.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

5.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

Review 6.  Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer.

Authors:  Caroline Wigerup; Sven Påhlman; Daniel Bexell
Journal:  Pharmacol Ther       Date:  2016-04-29       Impact factor: 12.310

Review 7.  Investigating hypoxic tumor physiology through gene expression patterns.

Authors:  Nicholas C Denko; Lucrezia A Fontana; Karen M Hudson; Patrick D Sutphin; Soumya Raychaudhuri; Russ Altman; Amato J Giaccia
Journal:  Oncogene       Date:  2003-09-01       Impact factor: 9.867

8.  HIF1α and HIF2α independently activate SRC to promote melanoma metastases.

Authors:  Sara C Hanna; Bhavani Krishnan; Sean T Bailey; Stergios J Moschos; Pei-Fen Kuan; Takeshi Shimamura; Lukas D Osborne; Marni B Siegel; Lyn M Duncan; E Tim O'Brien; Richard Superfine; C Ryan Miller; M Celeste Simon; Kwok-Kin Wong; William Y Kim
Journal:  J Clin Invest       Date:  2013-04-08       Impact factor: 14.808

Review 9.  The interplay between MYC and HIF in cancer.

Authors:  Chi V Dang; Jung-whan Kim; Ping Gao; Jason Yustein
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

10.  Molecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcome.

Authors:  Piotr Rutkowski; Aleksandra Gos; Monika Jurkowska; Tomasz Switaj; Wirginiusz Dziewirski; Marcin Zdzienicki; Konrad Ptaszyński; Wanda Michej; Andrzej Tysarowski; Janusz A Siedlecki
Journal:  Oncol Lett       Date:  2014-05-08       Impact factor: 2.967

View more
  19 in total

Review 1.  Modifiable Host Factors in Melanoma: Emerging Evidence for Obesity, Diet, Exercise, and the Microbiome.

Authors:  Allison Betof Warner; Jennifer L McQuade
Journal:  Curr Oncol Rep       Date:  2019-07-01       Impact factor: 5.075

Review 2.  The Role of Glypicans in Cancer Progression and Therapy.

Authors:  Nan Li; Madeline R Spetz; Mitchell Ho
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

3.  Development of novel parameter for monitoring of malignant melanoma progression.

Authors:  Ivana Špaková; Miroslava Rabajdová; Katarína Dubayová; Vladimíra Nagyová; Martina Bago Pilátová; Mária Mareková
Journal:  Pract Lab Med       Date:  2020-10-21

4.  Comparison of phosphorescent agents for noninvasive sensing of tumor oxygenation via Cherenkov-excited luminescence imaging.

Authors:  Jennifer Shell; Ethan P LaRochelle; Petr Bruza; Jason Gunn; Lesley Jarvis; David Gladstone; Brian Pogue
Journal:  J Biomed Opt       Date:  2019-03       Impact factor: 3.170

5.  Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.

Authors:  Yuanyuan Li; Melissa Li; Igor Shats; Juno M Krahn; Gordon P Flake; David M Umbach; Xiaoling Li; Leping Li
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

6.  GPC6 Promotes Cell Proliferation, Migration, and Invasion in Nasopharyngeal Carcinoma.

Authors:  Chunmei Fan; Chaofeng Tu; Peng Qi; Can Guo; Bo Xiang; Ming Zhou; Xiayu Li; Xu Wu; Xiaoling Li; Guiyuan Li; Wei Xiong; Zhaoyang Zeng
Journal:  J Cancer       Date:  2019-06-24       Impact factor: 4.207

7.  MITF controls the TCA cycle to modulate the melanoma hypoxia response.

Authors:  Pakavarin Louphrasitthiphol; Ioanna Ledaki; Jagat Chauhan; Paola Falletta; Robert Siddaway; Francesca M Buffa; David R Mole; Tomoyoshi Soga; Colin R Goding
Journal:  Pigment Cell Melanoma Res       Date:  2019-07-08       Impact factor: 4.693

8.  Biogenesis and functions of aminocarboxypropyluridine in tRNA.

Authors:  Mayuko Takakura; Kensuke Ishiguro; Shinichiro Akichika; Kenjyo Miyauchi; Tsutomu Suzuki
Journal:  Nat Commun       Date:  2019-12-05       Impact factor: 14.919

9.  Non-canonical Targets of HIF1a Impair Oligodendrocyte Progenitor Cell Function.

Authors:  Kevin C Allan; Lucille R Hu; Marissa A Scavuzzo; Andrew R Morton; Artur S Gevorgyan; Erin F Cohn; Benjamin L L Clayton; Ilya R Bederman; Stevephen Hung; Cynthia F Bartels; Mayur Madhavan; Paul J Tesar
Journal:  Cell Stem Cell       Date:  2020-10-21       Impact factor: 24.633

10.  Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix.

Authors:  Saioa Mendaza; Joaquín Fernández-Irigoyen; Enrique Santamaría; Tamara Zudaire; Rosa Guarch; David Guerrero-Setas; August Vidal; José Santos-Salas; Xavier Matias-Guiu; Karina Ausín; María José Díaz de Cerio; Esperanza Martín-Sánchez
Journal:  Int J Mol Sci       Date:  2020-03-19       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.